Medical devices, healthcare technology and the business of care
510(k) clearance · K261255

KOWA FM-600

Kowa Company, Ltd. Chofu Factory · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK261255

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K261255 on September 11, 2026, covering the KOWA FM-600 (LSS50D2), a Class II laser scanning ophthalmoscope under 21 CFR 886.1570, product code MYC, submitted by Kowa Company, Ltd. Chofu Factory. The device is described as a noninvasive flare photometry instrument that quantitatively assesses anterior protein level in the anterior chamber, intended for use by an ophthalmologist or ophthalmic technician. SESE is a 510(k) clearance, not a PMA approval.

The submission compares the device with predicate K091039, also a KOWA FM-600, citing the same intended use and measurement principle. Listed differences include a laser source wavelength change from 635 nm to 638 nm, a scanning mechanism change from galvanometer to MEMS mirror, laser output of 35 ± 15 µW versus less than 0.05 mW, a PS/2 to USB input terminal change, rest color change, and an added front view alignment mode. The summary states a comparison of front and side view alignment was performed; specific results are not given in the excerpts.

The public record shows a date received of 04/16/2026, while the clearance letter cites a dated date of August 5, 2026 and a received date of August 6, 2026; the discrepancy is unresolved in the available text. No clinical performance conclusions beyond the stated equivalence determination are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261255
Regulatory pathway
510(k) premarket notification
Product code
MYC
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ophthalmoscope, Laser, Scanning.

Product code
MYC
FDA device class
2

FDA decision timeline

  1. K261255 received

    Application receipt date recorded by FDA.

  2. K261255 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MYC

Product / regulatory recordCompanyPathwayDecision dateSource
Robotrak Technologies Co., Ltd.510(k) clearanceOct 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kowa Company, Ltd. Chofu Factory

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tokyo

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records